# Treatment Response of High-dose and Standard-dose Rabeprazole for Extra-esophageal Reflux.

> **NCT04001400** · PHASE3 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 73 (actual)

## Conditions studied

- Esophageal Disease

## Interventions

- **DRUG:** Rabeprazole 20mg bid
- **DRUG:** Rabeprazole 20mg qd

## Key facts

- **NCT ID:** NCT04001400
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10-10
- **Primary completion:** 2014-05-21
- **Final completion:** 2014-05-21
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2019-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04001400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04001400, "Treatment Response of High-dose and Standard-dose Rabeprazole for Extra-esophageal Reflux.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04001400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*